
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
PD-L1-Mediated Immunosuppression in Glioblastoma Is Associated With the Infiltration and M2-Polarization of Tumor-Associated Macrophages
Zhiyuan Zhu, Hongbo Zhang, Baodong Chen, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 117
Zhiyuan Zhu, Hongbo Zhang, Baodong Chen, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 117
Showing 1-25 of 117 citing articles:
Tumor-Associated Macrophages Regulate PD-1/PD-L1 Immunosuppression
Yunzhou Pu, Qing Ji
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 172
Yunzhou Pu, Qing Ji
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 172
Correlation between PD-1/PD-L1 expression and polarization in tumor-associated macrophages: A key player in tumor immunotherapy
Wei Li, Fenglei Wu, Shaolin Zhao, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 49-57
Open Access | Times Cited: 97
Wei Li, Fenglei Wu, Shaolin Zhao, et al.
Cytokine & Growth Factor Reviews (2022) Vol. 67, pp. 49-57
Open Access | Times Cited: 97
The role of the immunosuppressive PD-1/PD-L1 checkpoint pathway in the aging process and age-related diseases
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
Antero Salminen
Journal of Molecular Medicine (2024) Vol. 102, Iss. 6, pp. 733-750
Open Access | Times Cited: 22
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 17
Ke-Xun Yu, Weijie Yuan, Huizhen Wang, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 6
Open Access | Times Cited: 17
Glial Perturbation in Metal Neurotoxicity: Implications for Brain Disorders
Olayemi K. Ijomone, Ukwubile Ileje Inelo, Vivian O. Aneke, et al.
Neuroglia (2025) Vol. 6, Iss. 1, pp. 4-4
Open Access | Times Cited: 3
Olayemi K. Ijomone, Ukwubile Ileje Inelo, Vivian O. Aneke, et al.
Neuroglia (2025) Vol. 6, Iss. 1, pp. 4-4
Open Access | Times Cited: 3
Small interfering RNA (siRNA) to target genes and molecular pathways in glioblastoma therapy: Current status with an emphasis on delivery systems
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 89
Sepideh Mirzaei, Mahmood Khaksary Mahabady, Amirhossein Zabolian, et al.
Life Sciences (2021) Vol. 275, pp. 119368-119368
Closed Access | Times Cited: 89
Hypoxia-Driven M2-Polarized Macrophages Facilitate Cancer Aggressiveness and Temozolomide Resistance in Glioblastoma
Ge Zhang, Xiang Tao, Baowei Ji, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 41
Ge Zhang, Xiang Tao, Baowei Ji, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-20
Open Access | Times Cited: 41
Tumor-associated macrophage-related strategies for glioma immunotherapy
Fansong Tang, Yuelong Wang, Yunhui Zeng, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 36
Fansong Tang, Yuelong Wang, Yunhui Zeng, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 36
The NR_109/FUBP1/c-Myc axis regulates TAM polarization and remodels the tumor microenvironment to promote cancer development
Cong Zhang, Sisi Wei, Suli Dai, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006230-e006230
Open Access | Times Cited: 31
Cong Zhang, Sisi Wei, Suli Dai, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 5, pp. e006230-e006230
Open Access | Times Cited: 31
Targeting immune checkpoints on tumor-associated macrophages in tumor immunotherapy
Shumin Xu, Chenyang Wang, Lingge Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
Shumin Xu, Chenyang Wang, Lingge Yang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 28
The therapeutic potential of PD-1/PD-L1 pathway on immune-related diseases: Based on the innate and adaptive immune components
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 23
Peng Zhang, Yuting Wang, Qianru Miao, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 167, pp. 115569-115569
Open Access | Times Cited: 23
Glioma-associated macrophages: unraveling their dual role in the microenvironment and therapeutic implications
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Jiachen Wang, Shenglan Li, Yanjie Lan, et al.
Current Medicine (2024) Vol. 3, Iss. 1
Open Access | Times Cited: 9
Cooperation between inhibitory immune checkpoints of senescent cells with immunosuppressive network to promote immunosenescence and the aging process
Antero Salminen
Ageing Research Reviews (2025), pp. 102694-102694
Open Access | Times Cited: 1
Antero Salminen
Ageing Research Reviews (2025), pp. 102694-102694
Open Access | Times Cited: 1
Development of a novel gene signature to predict prognosis and response to PD-1 blockade in clear cell renal cell carcinoma
Xiaomao Yin, Zaoyu Wang, Jianfeng Wang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Xiaomao Yin, Zaoyu Wang, Jianfeng Wang, et al.
OncoImmunology (2021) Vol. 10, Iss. 1
Open Access | Times Cited: 43
Origin, activation, and targeted therapy of glioma-associated macrophages
Can Xu, Menglin Xiao, Xiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
Can Xu, Menglin Xiao, Xiang Li, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 36
The immunosuppressive microenvironment and immunotherapy in human glioblastoma
Xuehua Zhang, Leilei Zhao, He Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
Xuehua Zhang, Leilei Zhao, He Zhang, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 33
The Importance of M1-and M2-Polarized Macrophages in Glioma and as Potential Treatment Targets
Jiangbin Ren, Bangjie Xu, Jianghao Ren, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 22
Jiangbin Ren, Bangjie Xu, Jianghao Ren, et al.
Brain Sciences (2023) Vol. 13, Iss. 9, pp. 1269-1269
Open Access | Times Cited: 22
Phellinus linteus activates Treg cells via FAK to promote M2 macrophage polarization in hepatocellular carcinoma
Feihua Chen, Mouchun Gong, Dengcheng Weng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 1
Open Access | Times Cited: 7
Feihua Chen, Mouchun Gong, Dengcheng Weng, et al.
Cancer Immunology Immunotherapy (2024) Vol. 73, Iss. 1
Open Access | Times Cited: 7
M2 macrophages promote PD-L1 expression in triple-negative breast cancer via secreting CXCL1
Lifen Zhang, Shanzhi Gu, Lu Wang, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155458-155458
Open Access | Times Cited: 7
Lifen Zhang, Shanzhi Gu, Lu Wang, et al.
Pathology - Research and Practice (2024) Vol. 260, pp. 155458-155458
Open Access | Times Cited: 7
A Roadmap of CAR-T-Cell Therapy in Glioblastoma: Challenges and Future Perspectives
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
Megan Montoya, Marco Gallus, Su Phyu, et al.
Cells (2024) Vol. 13, Iss. 9, pp. 726-726
Open Access | Times Cited: 6
Tumor‐associated macrophages: A sentinel of innate immune system in tumor microenvironment gone haywire
Shaivy Malik, Niti Sureka, Sana Ahuja, et al.
Cell Biology International (2024) Vol. 48, Iss. 10, pp. 1406-1449
Closed Access | Times Cited: 6
Shaivy Malik, Niti Sureka, Sana Ahuja, et al.
Cell Biology International (2024) Vol. 48, Iss. 10, pp. 1406-1449
Closed Access | Times Cited: 6
Total Glucosides of Paeony Ameliorate Pristane-Induced Lupus Nephritis by Inducing PD-1 ligands+ Macrophages via Activating IL-4/STAT6/PD-L2 Signaling
Chun-Ling Liang, Hongliang Jiang, Wenxuan Feng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
Chun-Ling Liang, Hongliang Jiang, Wenxuan Feng, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 39
Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma
Miao Ye, Jifeng Liu, Xishu Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 27
Miao Ye, Jifeng Liu, Xishu Liu, et al.
Frontiers in Genetics (2022) Vol. 13
Open Access | Times Cited: 27
Aris J. Kare, Lisa Nichols, Ricardo Zermeno, et al.
Cytometry Part A (2023) Vol. 103, Iss. 11, pp. 839-850
Open Access | Times Cited: 15
Dual receptor specific nanoparticles targeting EGFR and PD-L1 for enhanced delivery of docetaxel in cancer therapy
Fakhrossadat Emami, Ramesh Duwa, Asmita Banstola, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115023-115023
Open Access | Times Cited: 13
Fakhrossadat Emami, Ramesh Duwa, Asmita Banstola, et al.
Biomedicine & Pharmacotherapy (2023) Vol. 165, pp. 115023-115023
Open Access | Times Cited: 13